contentSlug

type

ContentSlug_ContentQuery

slug

ContentPageContentQuery

content

trendingContent

query ContentSlug_ContentQuery(
  $contentSlug: String!
  $type: [ContentType!]
) {
  ...ContentPageContentQuery_13QmVO
}

fragment CompanyDetails_Content on Content {
  __isContent: __typename
  companies {
    name
    description
    pageUrl
    id
  }
}

fragment ContentBasicInfo on Content {
  __isContent: __typename
  id
  type
  title
  lang
  companies {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  tags {
    viewerIsFollowing
    id
    name
    pageUrl
  }
  ...PublishingDetails
  ...Reactions
}

fragment ContentMetadata on Content {
  __isContent: __typename
  type
  title
  lang
  pageUrl
  alternatePageUrls: translations {
    __typename
    pageUrl
    lang
  }
  imgUrl
  description
  ... on Video {
    liveTime
    videoUrl
  }
  ... on Webcast {
    liveTime
    videoUrl
  }
}

fragment ContentPageContentQuery_13QmVO on Query {
  content(slug: $contentSlug, type: $type) {
    __typename
    id
    type
    title
    isPremium
    lang
    htmlBody
    summary
    companies {
      forum {
        latestPosts {
          ...ForumPosts
        }
      }
      name
      id
      viewerIsFollowing
      pageUrl
      defaultInstrument {
        isin
        id
        marketOpen
        marketClose
        marketplace {
          region
        }
        returns {
          total
        }
      }
    }
    tags {
      viewerIsFollowing
      id
      name
      pageUrl
    }
    createdAt
    ... on Video {
      liveTime
    }
    ... on Webcast {
      liveTime
    }
    slug
    ... on CompanyReport {
      reportUrl
    }
    ... on ThirdPartyCompanyReport {
      reportUrl
    }
    ... on StockExchangeRelease {
      reportUrl
    }
    ...ContentBasicInfo
    ...ContentMetadata
    ...PriceAndRecommendation_Content
    ...CompanyDetails_Content
    ...ReportLink_Content
    ...KeyFigures_Content
  }
  ...TrendingContent_1jQ2Cn
}

fragment ForumPosts on ForumPost {
  text
  likesCount
  url
  author
  postedAt
  authorImgUrl
}

fragment KeyFigures_Content on Content {
  __isContent: __typename
  companies {
    defaultInstrument {
      estimateData {
        modelType
        reportingCurrency
      }
      snapshot {
        transaction {
          date
          actualized {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
          estimates {
            year
            quarter
            revenue
            revenueGrowth
            ebitAdjusted
            ebitReported
            ebitda
            enterpriseValue
            epsAdjusted
            dividend
            dividendYield
            sharePrice
            nav
            navPerShare
            opexOfNav
            quarterlySharePrice
          }
        }
      }
      id
    }
    id
  }
}

fragment PriceAndRecommendation_Content on Content {
  __isContent: __typename
  createdAt
  companies {
    name
    pageUrl
    defaultInstrument {
      priceData {
        tradeCurrency
      }
      snapshot {
        priceData {
          date
          lastPrice
          tradeCurrency
        }
        transaction {
          date
          recommendation
          targetPrice
        }
        prevTransaction {
          recommendation
        }
      }
      id
    }
    id
  }
}

fragment PublishingDetails on Content {
  __isContent: __typename
  createdAt
  publishers {
    name
    imgUrl
  }
  authors {
    __typename
    id
    name
    slug
    imgUrl
    jobTitle
  }
  ... on Video {
    liveTime
  }
  ... on Webcast {
    liveTime
  }
}

fragment Reactions on Content {
  __isContent: __typename
  id
  reactionGroups {
    reactionType
    reactionsCount
    viewerReacted
  }
}

fragment ReportLink_Content on Content {
  __isContent: __typename
  type
  isPremium
  ... on CompanyReport {
    reportUrl
  }
  ... on ThirdPartyCompanyReport {
    reportUrl
  }
  ... on StockExchangeRelease {
    reportUrl
  }
}

fragment TrendingContent_1jQ2Cn on Query {
  trendingContent(type: ARTICLE) {
    __typename
    id
    title
    lang
    pageUrl
    createdAt
    type
    imgUrl
    companies {
      squareLogoUrl
      name
      id
    }
    authors {
      __typename
      imgUrl
      id
    }
    publishers {
      imgUrl
    }
  }
}


scanfil-q4-numbers-slightly-below-consensus-fy-guidance-unchanged-nordea

__typename

title

isPremium

lang

htmlBody

summary

companies

createdAt

publishers

authors

reactionGroups

pageUrl

translations

imgUrl

description

Scanfil is an international electronics contract manufacturer, specializing in industrial and B2B customers. Services include manufacturing of end products and components such as PCBs. Manufacturing services are the core of the company, supported by design, supply chain and modernization services. The company operates globally in Europe, America and Asia. Customers are primarily found in the process automation, energy efficiency, green efficiency and medical segments.

Here are Antti’s quick comments on Scanfil’s Q4  Scanfil published its Q4 report this morning. The end-of-year figures remained at the level of the comparison period and did not quite reach our forecasts. On the other hand, growth in new projects sold continued to be good. Scanfil is set to continue its streak of dividend increases with another slight hike, roughly in line with expectations. Scanfil, of course, reiterated the guidance it provided in advance at the beginning of January. Based on our preliminary assessment, the report does not create significant pressure for changes to our near-term forecasts for Scanfil.                   Inderes              Scanfil Q4'25 -pikakommentti: Raportti tuskin aiheuttaa suurempaa...    Scanfilin loppuvuoden numerot jäivät vertailulukujen tasolle eivätkä aivan yltäneet ennusteisiimme.

Scanfil’s future looks good. Organic and inorganic growth ahead with strong profitability  “Our strength was evident in the EBITA, which we have been able to keep in the 7-8% range. In Q4, we achieved a strong comparable EBITA of 7.3%, which is in line with our targets and at last year’s level. Comparable EBITA for the full year was EUR 56.4 million and the margin was stable at 7.1%. It was a strong result, especially considering the high number of new projects and their impact on our efficiency.” October–December 2025 Net debt/EBITDA was 0.12 (0.29)  → The net debt to EBITDA ratio was 0.12 and the equity ratio was 53.9%. This gives us headroom to support organic and inorganic growth. Earnings per share was EUR 0.20 (0.14) Steady revenue growth continued during the quarter, and organic growth was 7.6%.   → Things are going strong in the USA: Among market segments, revenue in the Americas for Q4 2025 grew organically by 19.6% compared to Q4 2024. “In January, we announced a significant investment in the factory in China, where we have seen growing demand and a positive outlook. At the same time, we are ramping up the investments made in 2025 in Malaysia and the United States, which gives us confidence for 2026.” Future outlook for 2026 Scanfil estimates that revenue for 2026 will be EUR 940–1,060 million and comparable EBITA will be EUR 64–78 million (Revenue in 2025 was EUR 797.1 million.) Customer orders: In the final quarter, we recorded EUR 59.2 million worth of new customer projects. For the full year, we recorded a substantial EUR 219.7 million, representing a growth of 17.4% from last year.

I’ll also add the figures for the full year 2025 here to provide a better sense of the growth they are targeting: Revenue was EUR 797.1 million and comparable EBITA was 56.4.

Q4 results: October–December  Revenue was EUR 211.0 million (212.3), a decrease of 0.6% Revenue grew organically by 7.6% Comparable EBITA margin was 7.3% (7.3%) and comparable EBITA was EUR 15.5 (15.5) million Earnings per share was EUR 0.20 (0.14)  Outlook for 2026 Scanfil estimates its 2026 revenue to be EUR 940–1,060 million and comparable EBITA to be EUR 64–78 million.                   Inderes              Scanfil Oyj: Käänteentekevä vuosineljännes yhdistettynä vakaaseen orgaaniseen...    20.2.2026 08:00:00 EET | Scanfil Oyj | TilinpäätöstiedoteScanfil Oyj Tilinpäätöstiedote 20.2.2026 klo 8.00 Scanfil Oyj: Käänteentekevä vuosineljännes yhdistettynä vakaaseen orgaaniseen kasvuun...

Scanfil: Year of extraordinary performance - Nordea Tämä on kolmannen osapuolen analyysi, eikä välttämättä vastaa Inderesin näkemystä tai arvoja The most interesting aspect of the Q4 2025 earnings release came on 29 January, when Scanfil published its financial guidance for 2026. Overall, it is difficult to find any clear weak spots in Scanfil’s performance. Revenue growth is expected to exceed 20% in 2026, the customer base continues to expand, and exposure to structurally growing verticals is increasing. At the same time, profitability remains solid. In addition, the company’s healthy balance sheet provides ample flexibility for further acquisitions. Our estimate revisions are mainly driven by the timing of the two most recent acquisitions and the updated full‑year guidance. Our new fair value range is EUR 10.4–12.7 (9.8-12.0), based on an equal weighting of three valuation methods: DCF, EV/EBITDA and P/E. Based on our estimates, Scanfil’s EV/EBIT multiple for 2025E is now 10% below the peer group average, but the EMS sector as a whole has 15% higher valuation multiples than in 2010-24.                   Inderes              Scanfil: Year of extraordinary performance - Nordea - Inderes    The most interesting aspect of the Q4 2025 earnings release came on 29 January, when Scanfil published its financial guidance for 2026. Overall, it is difficult to find any clear weak spots ...

Chief Analyst Viljakainen has been hard at work on Sunday evening putting together a Scanfil pre-earnings report for us, as the company releases its Q4 report on Friday, Feb 20.  We are adjusting our target price for Scanfil to EUR 11.00 (prev. EUR 10.50), but lowering our recommendation to Reduce (prev. Accumulate). Scanfil’s guidance for 2026 was in line with expectations, which, together with MB’s strong 2025 figures, slightly lowered the risk level associated with the stock in our view. However, we did not make changes to our Scanfil forecasts beyond marginal positive fine-tuning at this stage. The approximately 15% share price increase since our December update has once again slightly raised the stock’s valuation (2026e: P/E 14x), and consequently, the expected return has, in our view, neutralized on a one-year horizon. In the longer term, we believe Scanfil still offers an attractive profitable growth investment case.                   Inderes              Scanfil Q4'25 -ennakko: Hyvä uutisvirta nykäisi löysät nopeasti pois - Inderes    Tarkistamme Scanfilin tavoitehintamme 11,00 euroon (aik. 10,50 €), mutta laskemme suosituksemme vähennä-tasolle (aik. lisää).

Here are Antti’s comments regarding Scanfil’s recent announcements  Scanfil announced its guidance for 2026 on Thursday. The midpoints of the wide guidance ranges were well in line with our current forecasts. Initially, we do not believe the guidance will cause significant pressure for changes to our or the consensus forecasts for Scanfil’s current year. However, the guidance, which hit expectations, slightly reduces the risks related to the organic and inorganic growth and earnings growth we have forecasted for this year.                   Inderes              Scanfilin kuluvan vuoden ohjeistus ei aiheuttanut yllätyksiä meille tai...    Leveiden ohjeistushaarukoiden keskikohdat olivat hyvin linjassa nykyisten ennusteidemme kanssa.                             Scanfil announced on Thursday that it is investing EUR 9 million in the expansion of its factory located in Suzhou, China. With the investment, the factory’s floor area will more than double. In Scanfil’s strategy, the Suzhou factory focuses especially on the Chinese local market, where, according to our understanding, the company has performed well in recent years. It supports long-term organic growth, but it does not cause immediate changes to our forecasts regarding investments or growth and earnings forecasts.                   Inderes              Scanfil investoi 9 MEUR Kiinan tehtaansa kasvattamiseen - Inderes    Tarpeelliselta vaikuttava investointi tukee Scanfilin pitkän aikavälin orgaanista kasvua, mutta se ei aiheuta välittömiä muutoksia ennusteisiimme.

Scanfil

Net sales and adj. EBITA were slightly below market consensus (LSEG) in Q4. However, profitability (EBITA%) was record high in Q4. Organic growth was 8% in Q4. Revenue growth was strongest in...

Net sales and adj. EBITA were slightly below market consensus (LSEG) in Q4. However, profitability (EBITA%) was record high in Q4. Organic growth was 8% in Q4. Revenue growth was strongest in the Americas region. The value of new projects won during 2025 grew by 17% y/y. Largest customer is 13% of net sales. Scanfil has completed two transformational acquisitions end of 2025. Full year 2026 guidance is unchanged. The relatively tight revenue guidance range indicates solid visibility on orders and end market demand we believe. Dividend proposal is EUR 0.25 (consensus EUR 0.24). With a resilient margin profile and supportive growth story versus peers, the risk/reward remains attractive, we believe.